Jennifer Compton
About Jennifer Compton
Jennifer Compton is a Research Scientist II at Bristol-Myers Squibb in New Jersey, United States.
Company
Jennifer Compton is employed at Bristol-Myers Squibb, a global biopharmaceutical company headquartered in New Jersey, United States. The company is known for discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. Jennifer contributes to the company's scientific endeavors in her role as a Research Scientist II.
Title
Jennifer Compton holds the position of Research Scientist II at Bristol-Myers Squibb. In this role, she coordinates activities related to the Chief Scientific Officer (CSO) within the Analytical and BioAnalytical Department. She is involved in a number of critical initiatives and teams at the company, contributing to both compliance and innovation efforts.
Education and Expertise
Jennifer Compton studied Biology at Liverpool John Moores University from 1986 to 1989. Prior to her university education, she attended Prenton High School for Girls from 1980 to 1984 and Mersey Park Primary School from 1972 to 1980. Her educational background has laid a solid foundation for her career in scientific research and analysis.
Background in Compliance and Documentation
As part of her role at Bristol-Myers Squibb, Jennifer Compton is a member of the Compliance global team. She plays a vital role in managing compliance within the company. Additionally, she is involved in the new Document Repository initiative for methods and participates in the new E logbook initiative. These responsibilities highlight her commitment to maintaining high standards in documentation and compliance.
Involvement in Global Teams
Jennifer Compton is an active member of several global teams at Bristol-Myers Squibb, including the ELN (Electronic Laboratory Notebook) global team. Through her involvement in these teams, she collaborates with colleagues across different regions to support and advance the company's scientific objectives. Her participation in these teams underscores her collaborative approach and dedication to scientific progress.